Lantern Pharma (LTRN) Tops Q3 EPS by 14c
Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.42), $0.14 better than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.42), $0.14 better than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.